From the abovementioned results, we can conclude that miR-320a has the potential to serve as a diagnostic biomarker for lung cancer, as its reduced expression correlates with PD-L1 overexpression in both the early and advanced stages of the disease. Here, CD274 is linked to lung carcinoma.